DOMESCO MEDICAL IMPORT-EXPORT JOINT STOCK CORPORATION

DOMESCO MEDICAL IMPORT-EXPORT JOINT STOCK CORPORATION (stock symbol: DMC) is one of Vietnam’s most established pharmaceutical manufacturers, with more than two decades of continuous operation and a strong position in both domestic distribution and export-oriented drug production.

Founded in 2003 and headquartered in Dong Thap Province, DOMESCO operates as a listed joint stock company on the Ho Chi Minh Stock Exchange (HOSE). The company specializes in the research, development, manufacturing, and trading of pharmaceuticals, including medicinal chemicals, botanical products, functional foods, and herbal-based healthcare products. It also maintains import–export activities in drugs, active ingredients, medical supplies, and equipment, providing a diversified revenue base within the healthcare value chain.

From a financial perspective, DOMESCO demonstrates a stable and resilient operating profile. Total assets stand at approximately USD 75.6 million, while annual sales reached about USD 78.0 million, reflecting steady top-line expansion. More importantly, profitability remains solid: net profit exceeded USD 8.3 million, with year-on-year growth returning after a temporary slowdown. Equity increased to USD 66.3 million, underscoring strong internal capital accumulation and a healthy balance sheet. Working capital remains high at over USD 53 million, providing substantial liquidity and operational flexibility.

A key distinguishing feature of DOMESCO is its shareholding structure and strategic backing. The company is majority-owned by Abbott Laboratories (Chile) Holdco SpA, which holds 51.69% of the shares. This foreign strategic ownership brings international standards in quality control, governance, and pharmaceutical manufacturing practices. In parallel, the State Capital Investment Corporation (SCIC) retains a significant minority stake, reinforcing DOMESCO’s position as a strategically important enterprise within Vietnam’s healthcare sector.

Operationally, DOMESCO employs around 950 staff and maintains a nationwide presence through branches in Hanoi, Da Nang, and Ho Chi Minh City, in addition to its main facilities in Dong Thap. This distribution network supports both hospital channels and retail pharmacies and facilitates export activities.

According to the assessment by Vanguard Business Information (VBI), available at https://www.vnbis.com, DOMESCO represents a high-quality pharmaceutical profile characterized by a long operating history, consistent profitability, strong liquidity, and credible foreign strategic ownership. These factors make the company a low-to-moderate risk counterparty for banks, suppliers, investors, and international partners seeking exposure to Vietnam’s pharmaceutical and healthcare market.